Eleusis Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 39

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $29M

Eleusis General Information

Description

Developer of psychedelic drug therapies intended to address unmet needs within and beyond psychiatry. The company's pipeline features a novel approach to transform psilocybin into a safe, effective, convenient, and affordable treatment alternative for depression, enabling healthcare providers and pharmaceutical companies to address a broad range of needs that are unmet by conventional therapies.

Contact Information

Website
www.eleusisltd.com
Formerly Known As
Eleusis Interim Holdings
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 25 Farringdon Street
  • 6th Floor
  • London EC4A 4AB
  • England, United Kingdom
Primary Industry
Drug Discovery
Vertical(s)
Life Sciences
Corporate Office
  • 25 Farringdon Street
  • 6th Floor
  • London EC4A 4AB
  • England, United Kingdom

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Eleusis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 20-Oct-2022 $29M Completed Generating Revenue
6. Reverse Merger 20-Jan-2022 Cancelled Clinical Trials - General
5. Later Stage VC 08-Jul-2020 Cancelled Clinical Trials - General
4. Later Stage VC (Series A) Completed Clinical Trials - General
3. Seed Round 27-Jun-2016 Completed Clinical Trials - General
2. Grant 01-Jul-2014 $16.1K $3.5M Completed Startup
1. Seed Round $3.5M $3.5M Completed Startup
To view Eleusis’s complete valuation and funding history, request access »

Eleusis Patents

  • 4

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 1

    Pending

  • Expiring in next 12 mo

Eleusis Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230277568-A1 Method of treatment for psilocybin or psilocin infusion Pending 10-Jul-2020
US-20200147038-A1 Assessing and treating psychedelic-responsive subjects Inactive 20-Apr-2017
US-20180036303-A1 Lsd for the treatment of alzheimer's disease Inactive 10-Mar-2015
US-20200085816-A1 Lsd for the treatment of alzheimer's disease Inactive 10-Mar-2015 A61K31/48

Eleusis Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Eleusis Acquisitions (1)

Eleusis’s most recent deal was a Merger/Acquisition with Kalypso Wellness Centers. The deal was made on 15-Jan-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Kalypso Wellness Centers 15-Jan-2021 Merger/Acquisition Clinics/Outpatient Services
To view Eleusis’s complete acquisitions history, request access »

Ready to get started?

Request a free trial

Eleusis FAQs

  • When was Eleusis founded?

    Eleusis was founded in 2013.

  • Where is Eleusis headquartered?

    Eleusis is headquartered in London, United Kingdom.

  • What is the size of Eleusis?

    Eleusis has 39 total employees.

  • What industry is Eleusis in?

    Eleusis’s primary industry is Drug Discovery.

  • Is Eleusis a private or public company?

    Eleusis is a Private company.

  • What is the current valuation of Eleusis?

    The current valuation of Eleusis is .

  • What is Eleusis’s current revenue?

    The current revenue for Eleusis is .

  • How much funding has Eleusis raised over time?

    Eleusis has raised $14.5M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »